Because rapid malignant transformation and tumour progression result in an unfavourable prognosis for patients with cancer, and because pAKT and/or TACO may accelerate HCC tumour cell growth, these molecules may be therapeutic targets. The gene discussed is CORO1A; the disease is neoplasm.